Follow
Pieter Evenepoel
Pieter Evenepoel
Unknown affiliation
Verified email at uzleuven.be
Title
Cited by
Cited by
Year
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
GA Block, KJ Martin, ALM De Francisco, SA Turner, MM Avram, ...
New England Journal of Medicine 350 (15), 1516-1525, 2004
14302004
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
M Ketteler, GA Block, P Evenepoel, M Fukagawa, CA Herzog, L McCann, ...
Kidney international 92 (1), 26-36, 2017
10612017
Uremic toxins originating from colonic microbial metabolism
P Evenepoel, BKI Meijers, BRM Bammens, K Verbeke
Kidney International 76, S12-S19, 2009
4782009
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients
B Bammens, P Evenepoel, H Keuleers, K Verbeke, Y Vanrenterghem
Kidney international 69 (6), 1081-1087, 2006
4262006
Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study
P Evenepoel, K Claes, D Kuypers, B Maes, B Bammens, ...
Nephrology Dialysis Transplantation 19 (5), 1281-1287, 2004
4032004
Role of the gut microbiome in uremia: a potential therapeutic target
A Ramezani, ZA Massy, B Meijers, P Evenepoel, R Vanholder, DS Raj
American Journal of Kidney Diseases 67 (3), 483-498, 2016
3862016
Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study
BD Maes, R Oyen, K Claes, P Evenepoel, D Kuypers, J Vanwalleghem, ...
Kidney international 65 (5), 1842-1849, 2004
3712004
Diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder: Synopsis of the kidney disease: improving global outcomes 2017 clinical …
M Ketteler, GA Block, P Evenepoel, M Fukagawa, CA Herzog, L McCann, ...
Annals of internal medicine 168 (6), 422-430, 2018
3602018
p-Cresol and cardiovascular risk in mild-to-moderate kidney disease
BKI Meijers, K Claes, B Bammens, H de Loor, L Viaene, K Verbeke, ...
Clinical journal of the american society of nephrology 5 (7), 1182-1189, 2010
3472010
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver …
W Laleman, A Wilmer, P Evenepoel, IV Elst, M Zeegers, Z Zaman, ...
Critical Care 10, 1-13, 2006
3462006
p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin
BKI Meijers, V De Preter, K Verbeke, Y Vanrenterghem, P Evenepoel
Nephrology Dialysis Transplantation 25 (1), 219-224, 2010
3402010
Free p-cresol is associated with cardiovascular disease in hemodialysis patients
BKI Meijers, B Bammens, B De Moor, K Verbeke, Y Vanrenterghem, ...
Kidney international 73 (10), 1174-1180, 2008
3382008
The gut–kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression
BKI Meijers, P Evenepoel
Nephrology Dialysis Transplantation 26 (3), 759-761, 2011
3232011
Influence of dietary protein supplements on the formation of bacterial metabolites in the colon.
B Geypens, D Claus, P Evenepoel, M Hiele, B Maes, M Peeters, ...
Gut 41 (1), 70-76, 1997
2701997
The gut–kidney axis
P Evenepoel, R Poesen, B Meijers
Pediatric Nephrology 32, 2005-2014, 2017
2622017
The uremic retention solute p-cresyl sulfate and markers of endothelial damage
BKI Meijers, K Verbeke, W Dehaen, Y Vanrenterghem, MF Hoylaerts, ...
American Journal of Kidney Diseases 54 (5), 891-901, 2009
2612009
Intrarenal resistive index after renal transplantation
M Naesens, L Heylen, E Lerut, K Claes, L De Wever, F Claus, R Oyen, ...
New England Journal of Medicine 369 (19), 1797-1806, 2013
2392013
Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms
B Bammens, P Evenepoel, K Verbeke, Y Vanrenterghem
Kidney international 64 (6), 2238-2243, 2003
2392003
Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study
B Bammens, P Evenepoel, K Verbeke, Y Vanrenterghem
American journal of kidney diseases 44 (2), 278-285, 2004
2192004
Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long‐term pharmacokinetics in de novo renal allograft recipients
DRJ Kuypers, K Claes, P Evenepoel, B Maes, Y Vanrenterghem
Clinical Pharmacology & Therapeutics 75 (5), 434-447, 2004
2172004
The system can't perform the operation now. Try again later.
Articles 1–20